Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Other Accumulated Expenses (2018 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Other Accumulated Expenses for 15 consecutive years, with $17.6 billion as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 3.01% to $17.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.6 billion through Dec 2025, down 3.01% year-over-year, with the annual reading at $17.6 billion for FY2025, 3.01% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $17.6 billion at Bristol Myers Squibb, down from $19.3 billion in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $19.3 billion in Q3 2025, with the low at $12.4 billion in Q1 2022.
  • Average Other Accumulated Expenses over 5 years is $15.2 billion, with a median of $14.9 billion recorded in 2022.
  • The sharpest move saw Other Accumulated Expenses dropped 19.19% in 2021, then increased 22.48% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $14.0 billion in 2021, then grew by 4.4% to $14.6 billion in 2022, then rose by 8.9% to $15.9 billion in 2023, then increased by 14.11% to $18.1 billion in 2024, then decreased by 3.01% to $17.6 billion in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $17.6 billion, $19.3 billion, and $17.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.